Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

completed267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_2

Clinical Performance of Zirconia Reinforced GI Versus Conventional Viscous GI in Geriatric Patients

NCT04298151
unknownnot_applicable

Clinical Performance and Wear Resistance of Highly Translucent Nano Zirconia Reinforced Glass Ionomer Filling Versus Conventional Resin Composite Restorations in Patients With Proximal Carious Teeth. (A One-year Randomized Clinical Trial).

NCT05403008
completednot_applicable

Evaluation of the Clinical Performance of Reinforced Glass Ionomer Restorations

NCT04288791

Clinical Trials (3)

Showing 3 of 3 trials
NCT04298151Phase 2

Clinical Performance of Zirconia Reinforced GI Versus Conventional Viscous GI in Geriatric Patients

Completed
NCT05403008Not Applicable

Clinical Performance and Wear Resistance of Highly Translucent Nano Zirconia Reinforced Glass Ionomer Filling Versus Conventional Resin Composite Restorations in Patients With Proximal Carious Teeth. (A One-year Randomized Clinical Trial).

Unknown
NCT04288791Not Applicable

Evaluation of the Clinical Performance of Reinforced Glass Ionomer Restorations

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3